Immediate Hematologic Stabilization in Suspected Multiple Myeloma

Platelet Management

White‑Blood‑Cell Management

Tumor‑Lysis‑Syndrome (TLS) Prophylaxis

Daily Monitoring During Stabilization

Diagnostic Workup for Suspected Multiple Myeloma

Laboratory Evaluation

Bone‑Marrow Assessment

Imaging Studies

Differentiating Multiple Myeloma from Metastatic Bone Disease

Initial Treatment Strategies

For Transplant‑Eligible Patients (generally age < 65–70 years, no severe comorbidities)

For Transplant‑Ineligible Patients

Supportive Care Measures

Ongoing Monitoring

Key Clinical Pitfalls to Avoid